The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. / Rerup, Sofie Aagaard; Bang, Lia E; Mogensen, Ulrik M; Engstrøm, Thomas; Jørgensen, Erik; Pedersen, Frants; Torp-Pedersen, Christian; Gislason, Gunnar; James, Stefan; Hagström, Emil; Køber, Lars; Fosbøl, Emil L.

In: American Heart Journal, Vol. 181, 11.2016, p. 35-42.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rerup, SA, Bang, LE, Mogensen, UM, Engstrøm, T, Jørgensen, E, Pedersen, F, Torp-Pedersen, C, Gislason, G, James, S, Hagström, E, Køber, L & Fosbøl, EL 2016, 'The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction', American Heart Journal, vol. 181, pp. 35-42. https://doi.org/10.1016/j.ahj.2016.08.001

APA

Rerup, S. A., Bang, L. E., Mogensen, U. M., Engstrøm, T., Jørgensen, E., Pedersen, F., Torp-Pedersen, C., Gislason, G., James, S., Hagström, E., Køber, L., & Fosbøl, E. L. (2016). The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. American Heart Journal, 181, 35-42. https://doi.org/10.1016/j.ahj.2016.08.001

Vancouver

Rerup SA, Bang LE, Mogensen UM, Engstrøm T, Jørgensen E, Pedersen F et al. The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. American Heart Journal. 2016 Nov;181:35-42. https://doi.org/10.1016/j.ahj.2016.08.001

Author

Rerup, Sofie Aagaard ; Bang, Lia E ; Mogensen, Ulrik M ; Engstrøm, Thomas ; Jørgensen, Erik ; Pedersen, Frants ; Torp-Pedersen, Christian ; Gislason, Gunnar ; James, Stefan ; Hagström, Emil ; Køber, Lars ; Fosbøl, Emil L. / The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction. In: American Heart Journal. 2016 ; Vol. 181. pp. 35-42.

Bibtex

@article{252e5a531747474dafcc0ee7a85c38fa,
title = "The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction",
abstract = "AIMS: Familial hypercholesterolemia (FH) is a common genetic disorder causing accelerated atherosclerosis and premature cardiovascular disease. The aim of this study was to examine the prevalence and prognostic significance of possible FH in patients with myocardial infarction (MI).METHODS AND RESULTS: By individual-level linkage of data from the Eastern Danish Heart Registry and national administrative registries, a study population of patients referred for coronary angiography due to MI was selected. The study population was divided into {"}unlikely FH{"} and {"}possible FH{"} based on the Dutch Lipid Clinic Network criteria, which included a plasma low-density lipoprotein cholesterol (LDL-C) and age for onset of cardiac disease. A score of ≥3 points was used as the cutpoint between the 2 groups. Among the study population of 13,174 MI patients, 1,281 (9.7%) had possible FH. These patients were younger (59.1 vs 65.7 years, P ≤ .0001), had similar levels of comorbidities, and were treated more aggressively with cholesterol-lowering drugs compared with patients with unlikely FH. During a median of 3.3 years of follow-up, the unadjusted and adjusted event rates of recurrent MI were higher in patients with possible FH compared with unlikely FH (16% vs 11%, adjusted hazard ratio 1.28, 95% CI 1.09-1.51, P = .003.). Differences in adjusted all-cause mortality were not statistically significant (17% vs 23%, adjusted hazard ratio 0.89 [0.74-1.04], P = .1).CONCLUSION: We found that MI patients with possible FH have higher risk of recurrent MI but similar risk of mortality compared with unlikely FH patients. Further studies on secondary prevention are warranted.",
author = "Rerup, {Sofie Aagaard} and Bang, {Lia E} and Mogensen, {Ulrik M} and Thomas Engstr{\o}m and Erik J{\o}rgensen and Frants Pedersen and Christian Torp-Pedersen and Gunnar Gislason and Stefan James and Emil Hagstr{\"o}m and Lars K{\o}ber and Fosb{\o}l, {Emil L}",
note = "Copyright {\textcopyright} 2016 Elsevier Inc. All rights reserved.",
year = "2016",
month = nov,
doi = "10.1016/j.ahj.2016.08.001",
language = "English",
volume = "181",
pages = "35--42",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",

}

RIS

TY - JOUR

T1 - The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction

AU - Rerup, Sofie Aagaard

AU - Bang, Lia E

AU - Mogensen, Ulrik M

AU - Engstrøm, Thomas

AU - Jørgensen, Erik

AU - Pedersen, Frants

AU - Torp-Pedersen, Christian

AU - Gislason, Gunnar

AU - James, Stefan

AU - Hagström, Emil

AU - Køber, Lars

AU - Fosbøl, Emil L

N1 - Copyright © 2016 Elsevier Inc. All rights reserved.

PY - 2016/11

Y1 - 2016/11

N2 - AIMS: Familial hypercholesterolemia (FH) is a common genetic disorder causing accelerated atherosclerosis and premature cardiovascular disease. The aim of this study was to examine the prevalence and prognostic significance of possible FH in patients with myocardial infarction (MI).METHODS AND RESULTS: By individual-level linkage of data from the Eastern Danish Heart Registry and national administrative registries, a study population of patients referred for coronary angiography due to MI was selected. The study population was divided into "unlikely FH" and "possible FH" based on the Dutch Lipid Clinic Network criteria, which included a plasma low-density lipoprotein cholesterol (LDL-C) and age for onset of cardiac disease. A score of ≥3 points was used as the cutpoint between the 2 groups. Among the study population of 13,174 MI patients, 1,281 (9.7%) had possible FH. These patients were younger (59.1 vs 65.7 years, P ≤ .0001), had similar levels of comorbidities, and were treated more aggressively with cholesterol-lowering drugs compared with patients with unlikely FH. During a median of 3.3 years of follow-up, the unadjusted and adjusted event rates of recurrent MI were higher in patients with possible FH compared with unlikely FH (16% vs 11%, adjusted hazard ratio 1.28, 95% CI 1.09-1.51, P = .003.). Differences in adjusted all-cause mortality were not statistically significant (17% vs 23%, adjusted hazard ratio 0.89 [0.74-1.04], P = .1).CONCLUSION: We found that MI patients with possible FH have higher risk of recurrent MI but similar risk of mortality compared with unlikely FH patients. Further studies on secondary prevention are warranted.

AB - AIMS: Familial hypercholesterolemia (FH) is a common genetic disorder causing accelerated atherosclerosis and premature cardiovascular disease. The aim of this study was to examine the prevalence and prognostic significance of possible FH in patients with myocardial infarction (MI).METHODS AND RESULTS: By individual-level linkage of data from the Eastern Danish Heart Registry and national administrative registries, a study population of patients referred for coronary angiography due to MI was selected. The study population was divided into "unlikely FH" and "possible FH" based on the Dutch Lipid Clinic Network criteria, which included a plasma low-density lipoprotein cholesterol (LDL-C) and age for onset of cardiac disease. A score of ≥3 points was used as the cutpoint between the 2 groups. Among the study population of 13,174 MI patients, 1,281 (9.7%) had possible FH. These patients were younger (59.1 vs 65.7 years, P ≤ .0001), had similar levels of comorbidities, and were treated more aggressively with cholesterol-lowering drugs compared with patients with unlikely FH. During a median of 3.3 years of follow-up, the unadjusted and adjusted event rates of recurrent MI were higher in patients with possible FH compared with unlikely FH (16% vs 11%, adjusted hazard ratio 1.28, 95% CI 1.09-1.51, P = .003.). Differences in adjusted all-cause mortality were not statistically significant (17% vs 23%, adjusted hazard ratio 0.89 [0.74-1.04], P = .1).CONCLUSION: We found that MI patients with possible FH have higher risk of recurrent MI but similar risk of mortality compared with unlikely FH patients. Further studies on secondary prevention are warranted.

U2 - 10.1016/j.ahj.2016.08.001

DO - 10.1016/j.ahj.2016.08.001

M3 - Journal article

C2 - 27823691

VL - 181

SP - 35

EP - 42

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

ER -

ID: 173780299